Repligen (RGEN) Shares Outstanding (Diluted Average) (2010 - 2022)
Repligen (RGEN) reported Shares Outstanding (Diluted Average) of $57455.0 for Q4 2022, little changed year-over-year from $57264.0 in Q4 2021, and little changed quarter-over-quarter from $57264.0 in Q4 2021.
Repligen (RGEN) Shares Outstanding (Diluted Average) (2010 - 2022) Analysis & Trends
Repligen (RGEN) has 10 years of Shares Outstanding (Diluted Average) data on file, last reported at $57455.0 in Q4 2022.
- Shares Outstanding (Diluted Average) for Q4 2022 came in at $57455.0, changed 0.33% year-over-year; the trailing twelve-month figure through Dec 2022 was $57455.0 (changed 0.33% YoY), and the FY2022 annual result was $57455.0, changed 0.33% from the prior year.
- Shares Outstanding (Diluted Average) was little changed at $57455.0 in Q4 2022 per RGEN's latest filing, from $57264.0 in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $56.9 million in Q1 2021 and troughed at $44327.0 in Q1 2018.
- A 5-year average of $31.9 million and a median of $47.0 million in 2019 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2019 and 2020: Shares Outstanding (Diluted Average) jumped 106605.45% in 2019, then sank 99.89% in 2020.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $45.5 million in 2018, then rose by 8.21% to $49.2 million in 2019, then slumped by 99.89% to $53892.0 in 2020, then climbed by 6.26% to $57264.0 in 2021, then grew by 0.33% to $57455.0 in 2022.
- Business Quant data shows RGEN's Shares Outstanding (Diluted Average) at $57455.0 in Q4 2022, $57264.0 in Q4 2021, and $56.8 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 57,455.00 |
| Dec 31, 2021 | 57,264.00 |
| Jun 30, 2021 | 56.82 Mn |
| Mar 31, 2021 | 56.87 Mn |
| Dec 31, 2020 | 53,892.00 |
| Sep 30, 2020 | 53.30 Mn |
| Jun 30, 2020 | 53.21 Mn |
| Mar 31, 2020 | 53.11 Mn |
| Dec 31, 2019 | 49.21 Mn |
| Sep 30, 2019 | 47.93 Mn |
| Jun 30, 2019 | 47.69 Mn |
| Mar 31, 2019 | 46.28 Mn |
| Dec 31, 2018 | 45.47 Mn |
| Sep 30, 2018 | 45,828.00 |
| Jun 30, 2018 | 44,695.00 |
| Mar 31, 2018 | 44,327.00 |
| Dec 31, 2017 | 39.15 Mn |
| Dec 31, 2016 | 34,099.00 |
| Mar 31, 2012 | 31.01 Mn |
| Dec 31, 2011 | 30.77 Mn |